User:Mary Mendoza/Notebook/CHEM572 Exp. Biological Chemistry II/2013/03/20

From OpenWetWare

(Difference between revisions)
Jump to: navigation, search
(Histogram)
(Histogram)
(4 intermediate revisions not shown.)
Line 13: Line 13:
* The aspirin trials did not show inhibition. A possible conclusion for the inconsistency was that the aspirin stock solution has deteriorated.
* The aspirin trials did not show inhibition. A possible conclusion for the inconsistency was that the aspirin stock solution has deteriorated.
* Kaempferol trials were started.
* Kaempferol trials were started.
-
* After examining some of the data, it was concluded to adjust the 40 μM adenosine concentration to 25 μM.
+
* After examining some of the data, it was concluded to adjust the 40 μM adenosine concentration to 25 μM. In addition, cuvettes will also contain 300 μL of DMSO.
 +
* For the following week, a new aspiring stock solution will be prepared.
 +
 
 +
==adenosine vs. aspirin==
 +
* The histogram below displays the non-inhibitory effect of aspirin.
 +
 
 +
[[Image:Bar2.png]]
 +
 
 +
==Tables==
 +
* The data below was taken from [[User:Dhea Patel/Notebook/CHEM 572: ADA&Inhibitor Kinetics/2013/03/20|Dhea Patel]].
 +
*To measure the mass of Kaempferol and the volume of DMSO:
 +
[[Image:Screen_Shot_2013-03-20_at_1.45.50_PM.png]]
 +
 
 +
*Table of volumes and concentrations:
 +
[[Image:Kinetics_Histogram_table.tiff|px550]]
 +
 
<!-- ##### DO NOT edit below this line unless you know what you are doing. ##### -->
<!-- ##### DO NOT edit below this line unless you know what you are doing. ##### -->

Revision as of 20:56, 22 March 2013

Project name Main project page
Previous entry      Next entry

Histogram

  • It was decided to create a histogram for each inhibitor which includes the flavonoids and the non-nucleoside, acetylsalicylic acid analogs. Each inhibitor consisted of three trials.
  • From Sigma, 500 μM Kaempferol (C15H10O6, MW 286.24 g/mol) stock solution was prepared in dimethylsulfoxide (DMSO).
  • A kinetic assay run of 40 μM adenosine without inhibitors was executed through the kinetics of the UVProbe system.
  • After the three trials of 40 μM adenosine, aspirin trials were conducted.
  • The aspirin trials did not show inhibition. A possible conclusion for the inconsistency was that the aspirin stock solution has deteriorated.
  • Kaempferol trials were started.
  • After examining some of the data, it was concluded to adjust the 40 μM adenosine concentration to 25 μM. In addition, cuvettes will also contain 300 μL of DMSO.
  • For the following week, a new aspiring stock solution will be prepared.

adenosine vs. aspirin

  • The histogram below displays the non-inhibitory effect of aspirin.

Image:Bar2.png

Tables

  • The data below was taken from Dhea Patel.
  • To measure the mass of Kaempferol and the volume of DMSO:

Image:Screen_Shot_2013-03-20_at_1.45.50_PM.png

  • Table of volumes and concentrations:

px550



Personal tools